Wave Life Sciences Ltd. (WVE) Financials

WVE Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 583.5 million 71.8 million
Dec. 31, 2025 638.5 million 112.3 million
Sept. 30, 2025 241.4 million 116.8 million
June 30, 2025 252.4 million 113.1 million

WVE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -60.0 million 9.1 million
Dec. 31, 2025 -32.1 million -17.6 million
Sept. 30, 2025 -44.9 million 6.5 million
June 30, 2025 -46.3 million 6.2 million

WVE Net Income

No data available :(

WVE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 544.6 million - 7.4 million
Dec. 31, 2025 602.1 million - 9.4 million
Sept. 30, 2025 196.2 million - 19.8 million
June 30, 2025 208.5 million - 21.7 million

WVE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 200.2 million
Dec. 31, 2025 180.2 million
Sept. 30, 2025 167.7 million
June 30, 2025 164.0 million

WVE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 438000 47.4 million 22.1 million -
Dec. 31, 2025 10009 52.8 million 20.9 million -
Sept. 30, 2025 248000 45.9 million 18.1 million -
June 30, 2025 306000 43.5 million 18.0 million -

WVE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 38.2 million -
Dec. 31, 2025 17.2 million 2.3 million
Sept. 30, 2025 7.6 million -
June 30, 2025 8.7 million 2.2 million

WVE

Price: $6.09

52 week price:
5.02
21.73

Earnings Per Share: -1.05 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Singapore

Volume: 358300

Ebitda: -26.4 million

Market Capitalization: 1.2 billion

Links: